NVCR SCHEDULE 13G/A: SEC filing
Soleus Capital Master Fund, L.P. and affiliated entities
Filed with the SEC on · accession 0001213900-26-117546
NVCR filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 9, 2026. A report the company filed with the SEC (the US market regulator).
Summary of the filing
Soleus Capital Master Fund, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 9,425,776 ordinary shares of NovoCure Ltd, representing approximately 8.1% of the outstanding shares as of September 30, 2026.
Key details
✦ Ask GOAX AI about this filing — what it means for NVCR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NVCR?
Click hereFrequently asked questions
What did NVCR file with the SEC on Nov 9, 2026?
NVCR filed a SCHEDULE 13G/A (SEC filing). Soleus Capital Master Fund, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 9,425,776 ordinary shares of NovoCure Ltd, representing approximately 8.1% of the outstanding shares as of September 30, 2026.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other NVCR SEC filings
Get alerts when NVCR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days